NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Titan Pharmaceuticals Inc (NASDAQ: TTNP)

 
TTNP Technical Analysis
1.5
As on 25th Apr 2025 TTNP STOCK Price closed @ 3.70 and we RECOMMEND Sell for LONG-TERM with Stoploss of 5.03 & Buy for SHORT-TERM with Stoploss of 0.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TTNPSTOCK Price

Open 3.75 Change Price %
High 4.11 1 Day -0.09 -2.37
Low 3.70 1 Week -0.02 -0.54
Close 3.70 1 Month 0.11 3.06
Volume 2564 1 Year 3.36 988.24
52 Week High 10.00 | 52 Week Low 0.26
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
GNLN 0.01 -50.00%
AGMH 0.05 25.00%
OMEX 1.51 77.65%
NVDA 111.01 4.30%
WW 0.40 166.67%
TSLA 284.95 9.80%
INTC 20.05 -6.70%
OPEN 0.76 -2.56%
LMDX 0.02 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
ZWZZT 25.00 2375.25%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
WW 0.40 166.67%
WINVR 0.12 140.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
ATMH 0.04 -60.00%
MILEW 0.06 -53.85%
LOTZW 0.01 -50.00%
 
 
TTNP
Daily Charts
TTNP
Intraday Charts
Whats New @
Bazaartrend
TTNP
Free Analysis
 
TTNP Important Levels Intraday
RESISTANCE4.49
RESISTANCE4.24
RESISTANCE4.08
RESISTANCE3.92
SUPPORT3.48
SUPPORT3.32
SUPPORT3.16
SUPPORT2.91
 
TTNP Forecast April 2025
4th UP Forecast19.48
3rd UP Forecast14.42
2nd UP Forecast11.29
1st UP Forecast8.16
1st DOWN Forecast-0.76
2nd DOWN Forecast-3.89
3rd DOWN Forecast-7.02
4th DOWN Forecast-12.08
 
TTNP Weekly Forecast
4th UP Forecast4.20
3rd UP Forecast4.04
2nd UP Forecast3.94
1st UP Forecast3.84
1st DOWN Forecast3.56
2nd DOWN Forecast3.46
3rd DOWN Forecast3.36
4th DOWN Forecast3.20
 
TTNP Forecast2025
4th UP Forecast31.74
3rd UP Forecast22.75
2nd UP Forecast17.19
1st UP Forecast11.63
1st DOWN Forecast-4.23
2nd DOWN Forecast-9.79
3rd DOWN Forecast-15.35
4th DOWN Forecast-24.34
 
 
TTNP Other Details
Segment EQ
Market Capital 17600460.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
TTNP Address
TTNP
 
TTNP Latest News
 
Your Comments and Response on Titan Pharmaceuticals Inc
 
TTNP Business Profile
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program, TP-2021 for use in combination with ProNeura technology for treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including non-clinical evaluation of the ProNeura platform in malaria prophylaxis. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California. Address: 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service